GenOway

GenOway

A global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
investor

€0.0

round
N/A

€5.6m

Private Placement VC
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2018201920202021202220232024
Revenues0000000000000000000000000000
% growth-(5 %)16 %27 %22 %18 %10 %
EBITDA0000000000000000000000000000
% EBITDA margin10 %4 %9 %11 %19 %30 %23 %
Profit0000000000000000000000000000
% profit margin-(11 %)(6 %)(2 %)5 %8 %8 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue80 %106 %64 %----

Source: Company filings or news article

Notes (0)
More about GenOway
Made with AI
Edit

Genoway specializes in the development of genetically modified mouse and rat models, serving the scientific research community. Operating in the biotechnology sector, the company collaborates closely with research institutions and pharmaceutical companies to provide customized transgenic animal models. Genoway's business model revolves around offering tailored solutions that meet specific research needs, utilizing both classical and innovative transgenesis technologies. Revenue is generated through project-based collaborations, where clients benefit from Genoway's expertise in creating models that accurately mimic human physiological responses. The company is recognized for its flexibility, allowing for bespoke project designs and frequent client communication. Key clients include universities and research organizations seeking reliable and precise animal models for their studies.

Keywords: transgenic, biotechnology, mouse models, rat models, scientific research, customized solutions, transgenesis, physiological relevancy, project-based, collaboration.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by GenOway

Edit
Axenis
ACQUISITION by GenOway Sep 2018